{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:33:03Z","timestamp":1790285583937,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bcmd.2015.12.004","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T11:43:49Z","timestamp":1450093429000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites"],"prefix":"10.1016","volume":"57","author":[{"given":"Cong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunshui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcmd.2015.12.004_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcmd.2015.12.004_bb0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas","volume":"8","author":"Zucca","year":"1997","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.bcmd.2015.12.004_bb0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1008313229892","article-title":"Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites","volume":"10","author":"Zucca","year":"1999","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.bcmd.2015.12.004_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation\u2014a population-based study of 1575 cases","volume":"124","author":"Moller","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"Suppl. 3","key":"10.1016\/j.bcmd.2015.12.004_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/annonc\/11.suppl_3.219","article-title":"Extranodal lymphomas","volume":"11","author":"Zucca","year":"2000","journal-title":"Ann. Oncol."},{"issue":"17","key":"10.1016\/j.bcmd.2015.12.004_bb0030","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1002\/cncr.27381","article-title":"Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era","volume":"118","author":"Takahashi","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bcmd.2015.12.004_bb0035","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/annonc\/mds150","article-title":"Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study","volume":"23","author":"de Leval","year":"2012","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajh.21353","article-title":"Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors","volume":"84","author":"Validire","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.004_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2003.11.141","article-title":"Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group","volume":"21","author":"Zucca","year":"2003","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database","volume":"89","author":"Castillo","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.004_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.bcmd.2015.12.004_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer (Oxford, England: 1990)"},{"issue":"6","key":"10.1016\/j.bcmd.2015.12.004_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R","article-title":"The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites","volume":"72","author":"Newton","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.004_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdg004","article-title":"Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre west population-based NHL registry","volume":"14","author":"Krol","year":"2003","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.bcmd.2015.12.004_bb0080","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","article-title":"Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin","volume":"23","author":"Lopez-Guillermo","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s12185-013-1282-3","article-title":"Prognostic value of Waldeyer's ring involvement of diffuse large B-cell lymphoma treated with R-CHOP","volume":"97","author":"Oh","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"12","key":"10.1016\/j.bcmd.2015.12.004_bb0090","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/annonc\/mdn525","article-title":"Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management","volume":"19","author":"Psyrri","year":"2008","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.bcmd.2015.12.004_bb0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00277-013-1701-9","article-title":"A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components","volume":"92","author":"Li","year":"2013","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0100","first-page":"453","article-title":"Extranodal non-Hodgkin's lymphomas\u2014a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas","volume":"9","author":"Lal","year":"2008","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350051","article-title":"Gastrointestinal lymphoma: recent advances in diagnosis and treatment","volume":"87","author":"Nakamura","year":"2013","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.bcmd.2015.12.004_bb0110","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2010-06-288480","article-title":"Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone","volume":"117","author":"Kim","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2015.12.004_bb0115","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/annonc\/mdg495","article-title":"Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma","volume":"14","author":"Binn","year":"2003","journal-title":"Ann. Oncol."},{"issue":"28","key":"10.1016\/j.bcmd.2015.12.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.04.031","article-title":"Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96).","volume":"23","author":"Koch","year":"2005","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.bcmd.2015.12.004_bb0125","first-page":"589","article-title":"Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases","volume":"42","author":"Yang","year":"2013","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"28","key":"10.1016\/j.bcmd.2015.12.004_bb0130","first-page":"2209","article-title":"Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases","volume":"93","author":"Zhang","year":"2013","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.bcmd.2015.12.004_bb0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0609.2011.01679.x","article-title":"Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution","volume":"87","author":"Fukuhara","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.12.004_bb0140","doi-asserted-by":"crossref","first-page":"269034","DOI":"10.1155\/2013\/269034","article-title":"Survival and failure outcomes in primary thyroid lymphomas: a single centre experience of combined modality approach","volume":"2013","author":"Kumar","year":"2013","journal-title":"J. Thyroid. Res."},{"key":"10.1016\/j.bcmd.2015.12.004_bb0145","article-title":"Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium","author":"Deng","year":"2015","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.bcmd.2015.12.004_bb0150","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ctrv.2014.05.010","article-title":"Primary breast lymphoma","volume":"40","author":"Cheah","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.bcmd.2015.12.004_bb0155","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/annonc\/mdt192","article-title":"Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options","volume":"24","author":"Aviv","year":"2013","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.004_bb0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2015.12.004_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.leukres.2011.12.012","article-title":"The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"36","author":"Castillo","year":"2012","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.bcmd.2015.12.004_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12185-009-0353-y","article-title":"Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab","volume":"90","author":"Ilic","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2015.12.004_bb0175","first-page":"146","article-title":"Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma. Ai zheng = aizheng =","volume":"28","author":"Xia","year":"2009","journal-title":"Chin. J. Cancer"},{"issue":"24","key":"10.1016\/j.bcmd.2015.12.004_bb0180","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1002\/cncr.25307","article-title":"Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients","volume":"116","author":"Zinzani","year":"2010","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.bcmd.2015.12.004_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-010-0990-5","article-title":"A systematic review and meta-analysis of rituximab-based immunochemotherapy for subtypes of diffuse large B cell lymphoma","volume":"89","author":"Fang","year":"2010","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2015.12.004_bb0190","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7314\/APJCP.2013.14.2.929","article-title":"Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases","volume":"14","author":"Zhou","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.bcmd.2015.12.004_bb0195","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.7314\/APJCP.2012.13.4.1341","article-title":"Prognostic sub-grouping of diffuse large B-cell lymphomas into germinal centre and post germinal centre groups by immunohistochemistry after 6 cycles of chemotherapy","volume":"13","author":"Hassan","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.bcmd.2015.12.004_bb0200","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clml.2011.05.037","article-title":"Biological characterization of nodal versus extranodal presentation of diffuse large B-cell lymphoma using immunohistochemistry","volume":"11","author":"Kim","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/modpathol.3800266","article-title":"Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype","volume":"18","author":"Yoshida","year":"2005","journal-title":"Mod. Pathol."},{"issue":"12","key":"10.1016\/j.bcmd.2015.12.004_bb0210","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.3800691","article-title":"Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases","volume":"19","author":"Al-Abbadi","year":"2006","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23638","article-title":"Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database","volume":"89","author":"Castillo","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.12.004_bb0220","first-page":"453","article-title":"Extranodal non-Hodgkin's lymphomas \u2014 a retrospective review of clinico-pathologic features and outcomes in comparison with nodal Non-Hodgkin's lymphomas","volume":"9","author":"Lal","year":"2008","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.bcmd.2015.12.004_bb0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcmd.2015.12.004_bb0230","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ajh.24169","article-title":"Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET\/CT and rituximab era: a Danish\u2013Canadian study of 443 patients with diffuse-large B-cell lymphoma","volume":"90","author":"El-Galaly","year":"2015","journal-title":"Am. J. Hematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961530019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107997961530019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:53Z","timestamp":1761049913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107997961530019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":46,"alternative-id":["S107997961530019X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.12.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}